在低资源环境中管理 Paroxysmal 夜间血红蛋白尿的艰巨任务:一个案例报告. 一个血液学家的经验
Musa Kasadhakawo Waiswa1, Christine Sekaggya-Wiltshire1, Emmanuel Seremba1
1Department of Medicine, Makerere University College of Health Sciences.
African health sciences
|August 8, 2025
概括
阴性夜间血红蛋白尿 (PNH) 是一种罕见的红细胞疾病. 通过流细胞测量进行早期诊断对于管理血液溶解性贫血和血栓形成风险至关重要.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 性夜间血红蛋白尿 (PNH) 是红细胞膜的缺陷.
- 它的特征是补体敏感性,血管内血解,血红素尿,血栓形成和全细胞减小.
- 诊断依赖于流细胞计检测由于PIG-A基因突变导致的GPI缺陷克隆.
研究的目的:
- 突出考虑PNH在患有不明原因血液溶解性贫血和血栓形成的患者中的重要性.
- 强调诊断工作,包括PNH的流细胞计.
主要方法:
- 一个34岁的男性病例报告,患有复发性血液溶解性贫血和持续性静脉鼻血栓.
- 通过PNH的流细胞计证实了诊断.
- 目前的管理包括抗凝药,补充剂和类固醇.
主要成果:
- 根据临床表现和流细胞计结果,该患者被诊断为PNH.
- 该案例说明了PNH的诊断挑战和管理.
结论:
- 对于复发性血液溶解性贫血和不寻常的血栓形成,PNH应该是差异诊断.
- 区分血红素尿与血液尿和利用流细胞计是及时PNH诊断和管理的关键.
相关概念视频
Hemodialysis III: Nursing Management
187
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
187
Peritoneal Dialysis III: Nursing Management
140
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
140
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Hemodialysis II: Procedure and Complications
131
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
131
Hemodialysis I: Introduction
290
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
290
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K


